Literature DB >> 29634288

Depression in type 1 diabetes and risk of dementia.

Paola Gilsanz1,2, Michal Schnaider Beeri3,4, Andrew J Karter1, Charles P Quesenberry1, Alyce S Adams1, Rachel A Whitmer1,2.   

Abstract

OBJECTIVE: Depression afflicts 14% of individuals with type 1 diabetes (T1D). Depression is a robust risk factor for dementia but it is unknown if this holds true for individuals with T1D, who recently started living to an age conferring dementia risk. We examined if depression is a dementia risk factor among elderly individuals with T1D.
METHODS: 3,742 individuals with T1D age ≥50 were followed for dementia from 1/1/96-9/30/2015. Depression, dementia, and comorbidities were abstracted from electronic medical records. Cox proportional hazard models estimated the association between depression and dementia adjusting for demographics, glycosylated hemoglobin, severe dysglycemic epidsodes, stroke, heart disease, nephropathy, and end stage renal disease. The cumulative incidence of dementia by depression was estimated conditional on survival dementia-free to age 55.
RESULTS: Five percent (N = 182) were diagnosed with dementia and 20% had baseline depression. Depression was associated with a 72% increase in dementia (fully adjusted HR = 1.72; 95% CI:1.12-2.65). The 25-year cumulative incidence of dementia was more than double for those with versus without depression (27% vs. 12%).
CONCLUSIONS: For people with T1D, depression significantly increases dementia risk. Given the pervasiveness of depression in T1D, this has major implications for successful aging in this population recently living to old age.

Entities:  

Keywords:  Type 1 diabetes; cohort; dementia; depression

Mesh:

Year:  2018        PMID: 29634288      PMCID: PMC6179940          DOI: 10.1080/13607863.2018.1455167

Source DB:  PubMed          Journal:  Aging Ment Health        ISSN: 1360-7863            Impact factor:   3.658


  48 in total

1.  Some evidence refuting the HMO "favorable selection" hypothesis: the case of Kaiser Permanente.

Authors:  N P Gordon; G A Kaplan
Journal:  Adv Health Econ Health Serv Res       Date:  1991

2.  Midlife cardiovascular risk factors and risk of dementia in late life.

Authors:  R A Whitmer; S Sidney; J Selby; S Claiborne Johnston; K Yaffe
Journal:  Neurology       Date:  2005-01-25       Impact factor: 9.910

3.  Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology.

Authors:  N Krieger
Journal:  Am J Public Health       Date:  1992-05       Impact factor: 9.308

Review 4.  The prevalence of co-morbid depression in adults with Type 1 diabetes: systematic literature review.

Authors:  K D Barnard; T C Skinner; R Peveler
Journal:  Diabet Med       Date:  2006-04       Impact factor: 4.359

5.  Association between diabetes and depression: Sex and age differences.

Authors:  W Zhao; Y Chen; M Lin; R J Sigal
Journal:  Public Health       Date:  2006-07-07       Impact factor: 2.427

Review 6.  Depression in type 1 diabetes in children: natural history and correlates.

Authors:  Margaret Grey; Robin Whittemore; William Tamborlane
Journal:  J Psychosom Res       Date:  2002-10       Impact factor: 3.006

7.  Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro.

Authors:  A Beiser; R B D'Agostino; S Seshadri; L M Sullivan; P A Wolf
Journal:  Stat Med       Date:  2000 Jun 15-30       Impact factor: 2.373

8.  Ethnic disparities in diabetic complications in an insured population.

Authors:  Andrew J Karter; Assiamira Ferrara; Jennifer Y Liu; Howard H Moffet; Lynn M Ackerson; Joe V Selby
Journal:  JAMA       Date:  2002-05-15       Impact factor: 56.272

9.  Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis.

Authors:  Raymond L Ownby; Elizabeth Crocco; Amarilis Acevedo; Vineeth John; David Loewenstein
Journal:  Arch Gen Psychiatry       Date:  2006-05

Review 10.  Vascular cognitive impairment.

Authors:  John T O'Brien; Timo Erkinjuntti; Barry Reisberg; Gustavo Roman; Tohru Sawada; Leonardo Pantoni; John V Bowler; Clive Ballard; Charles DeCarli; Philip B Gorelick; Kenneth Rockwood; Alistair Burns; Serge Gauthier; Steven T DeKosky
Journal:  Lancet Neurol       Date:  2003-02       Impact factor: 44.182

View more
  2 in total

Review 1.  Potential application of helminth therapy for resolution of neuroinflammation in neuropsychiatric disorders.

Authors:  Amir Abdoli; Hoda Mirzaian Ardakani
Journal:  Metab Brain Dis       Date:  2019-07-27       Impact factor: 3.584

2.  Metformin Decreases Insulin Resistance in Type 1 Diabetes Through Regulating p53 and RAP2A in vitro and in vivo.

Authors:  Gao-Fei Ren; Li-Li Xiao; Xiao-Jun Ma; Yu-Shan Yan; Peng-Fei Jiao
Journal:  Drug Des Devel Ther       Date:  2020-06-17       Impact factor: 4.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.